NO149175C - Fremgangsmaate til fremstilling av antibakterielt aktive rifamycin p-derivater - Google Patents
Fremgangsmaate til fremstilling av antibakterielt aktive rifamycin p-derivaterInfo
- Publication number
- NO149175C NO149175C NO771721A NO771721A NO149175C NO 149175 C NO149175 C NO 149175C NO 771721 A NO771721 A NO 771721A NO 771721 A NO771721 A NO 771721A NO 149175 C NO149175 C NO 149175C
- Authority
- NO
- Norway
- Prior art keywords
- antibactery
- rifamycine
- derivatives
- procedure
- active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB22206/76A GB1523199A (en) | 1976-05-28 | 1976-05-28 | Rifamycin sv derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO771721L NO771721L (no) | 1977-11-29 |
| NO149175B NO149175B (no) | 1983-11-21 |
| NO149175C true NO149175C (no) | 1984-02-29 |
Family
ID=10175646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO771721A NO149175C (no) | 1976-05-28 | 1977-05-16 | Fremgangsmaate til fremstilling av antibakterielt aktive rifamycin p-derivater |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4144234A (de) |
| JP (1) | JPS603316B2 (de) |
| AT (1) | AT350721B (de) |
| AU (1) | AU510254B2 (de) |
| BE (1) | BE855153A (de) |
| CA (1) | CA1061783A (de) |
| CH (1) | CH622808A5 (de) |
| DE (1) | DE2720088A1 (de) |
| DK (1) | DK149859C (de) |
| FI (1) | FI62098C (de) |
| FR (1) | FR2366298A1 (de) |
| GB (1) | GB1523199A (de) |
| HK (1) | HK15079A (de) |
| IE (1) | IE45729B1 (de) |
| IL (1) | IL51861A (de) |
| LU (1) | LU77427A1 (de) |
| NL (1) | NL181011C (de) |
| NO (1) | NO149175C (de) |
| PH (2) | PH13580A (de) |
| SE (1) | SE439311B (de) |
| ZA (1) | ZA772204B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1576886A (en) * | 1977-04-20 | 1980-10-15 | Lepetit Spa | Rifamycin derivatives |
| IT1111173B (it) * | 1978-04-27 | 1986-01-13 | Lepetit Spa | Derivati rifamicinici |
| GB2175964B (en) * | 1985-05-14 | 1989-07-05 | Francis V Mutolo | Linear motion bearing and shafts |
| GB8531887D0 (en) * | 1985-12-30 | 1986-02-05 | Lepetit Spa | Rifamycin sv derivatives |
| ES2124708T3 (es) * | 1991-01-28 | 1999-02-16 | Lepetit Spa | Nuevo procedimiento para preparar 2'-(dietilamino)rifamicina p (p/dea). |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1795568C3 (de) * | 1964-07-31 | 1974-07-18 | Gruppo Lepetit S.P.A., Mailand (Italien) | 3-Hydroxymethyl-rifamycin SV und Verfahren zu seiner Herstellung. Ausscheidung aus: 1595883 |
| GB1165179A (en) * | 1966-10-25 | 1969-09-24 | Lepetit Spa | Derivatives of Rifamycin SV |
| GB1172155A (en) * | 1967-03-01 | 1969-11-26 | Lepetit Spa | New Rifamycins |
| GB1470426A (en) * | 1974-08-30 | 1977-04-14 | Lepetit Spa | Rifamycins |
-
1976
- 1976-05-28 GB GB22206/76A patent/GB1523199A/en not_active Expired
-
1977
- 1977-04-07 AU AU24110/77A patent/AU510254B2/en not_active Expired
- 1977-04-11 IL IL51861A patent/IL51861A/xx unknown
- 1977-04-12 ZA ZA00772204A patent/ZA772204B/xx unknown
- 1977-04-20 PH PH19690A patent/PH13580A/en unknown
- 1977-04-20 NL NLAANVRAGE7704298,A patent/NL181011C/xx not_active IP Right Cessation
- 1977-04-21 FI FI771267A patent/FI62098C/fi not_active IP Right Cessation
- 1977-05-05 DE DE19772720088 patent/DE2720088A1/de active Granted
- 1977-05-12 US US05/796,290 patent/US4144234A/en not_active Expired - Lifetime
- 1977-05-16 NO NO771721A patent/NO149175C/no unknown
- 1977-05-26 LU LU77427A patent/LU77427A1/xx unknown
- 1977-05-26 JP JP52061707A patent/JPS603316B2/ja not_active Expired
- 1977-05-26 SE SE7706190A patent/SE439311B/xx not_active IP Right Cessation
- 1977-05-26 AT AT377877A patent/AT350721B/de not_active IP Right Cessation
- 1977-05-27 DK DK233877A patent/DK149859C/da not_active IP Right Cessation
- 1977-05-27 CH CH655977A patent/CH622808A5/fr not_active IP Right Cessation
- 1977-05-27 FR FR7716342A patent/FR2366298A1/fr active Granted
- 1977-05-27 BE BE178006A patent/BE855153A/xx not_active IP Right Cessation
- 1977-05-27 IE IE1098/77A patent/IE45729B1/en not_active IP Right Cessation
- 1977-05-30 CA CA279,466A patent/CA1061783A/en not_active Expired
-
1978
- 1978-07-20 PH PH21406A patent/PH16894A/en unknown
-
1979
- 1979-03-22 HK HK150/79A patent/HK15079A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI62098C (fi) | 1982-11-10 |
| FI771267A (de) | 1977-11-29 |
| IL51861A (en) | 1980-05-30 |
| PH13580A (en) | 1980-07-16 |
| DK149859C (da) | 1987-04-21 |
| CA1061783A (en) | 1979-09-04 |
| AU510254B2 (en) | 1980-06-19 |
| NL7704298A (nl) | 1977-11-30 |
| FR2366298A1 (fr) | 1978-04-28 |
| DK233877A (da) | 1977-11-29 |
| US4144234A (en) | 1979-03-13 |
| SE439311B (sv) | 1985-06-10 |
| LU77427A1 (de) | 1977-12-14 |
| NL181011C (nl) | 1987-06-01 |
| BE855153A (fr) | 1977-11-28 |
| JPS603316B2 (ja) | 1985-01-26 |
| DE2720088A1 (de) | 1977-12-15 |
| JPS5321199A (en) | 1978-02-27 |
| ZA772204B (en) | 1978-03-29 |
| CH622808A5 (de) | 1981-04-30 |
| IE45729L (en) | 1977-11-28 |
| AT350721B (de) | 1979-06-11 |
| GB1523199A (en) | 1978-08-31 |
| DE2720088C2 (de) | 1987-12-23 |
| NO149175B (no) | 1983-11-21 |
| IE45729B1 (en) | 1982-11-17 |
| HK15079A (en) | 1979-03-30 |
| FI62098B (fi) | 1982-07-30 |
| ATA377877A (de) | 1978-11-15 |
| IL51861A0 (en) | 1977-06-30 |
| SE7706190L (sv) | 1977-11-29 |
| DK149859B (da) | 1986-10-13 |
| PH16894A (en) | 1984-04-02 |
| FR2366298B1 (de) | 1981-01-16 |
| NO771721L (no) | 1977-11-29 |
| AU2411077A (en) | 1978-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO147243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater | |
| NO148148C (no) | Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater | |
| NO151411C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
| NO774404L (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| NO144848C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater | |
| NO145842C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater | |
| SE441354B (sv) | Forfarande for framstellning av meta-fenoxibensaldehyd | |
| NO147913C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner | |
| SE435387B (sv) | Forfarande for framstellning av antracyklinglykosider | |
| NO143992C (no) | Fremgangsmaate for fremstilling av heksanitrostilben | |
| NO821848L (no) | Fremgangsmaate for fremstilling av gamma-pyron-derivater | |
| NO772960L (no) | Fremgangsmaate til fremstilling av cefalosporinderivater | |
| NO770643L (no) | Fremgangsmaate til fremstilling av bilologisk aktive kopolymerer | |
| NO148291C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater | |
| NO148488C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater | |
| NO145163C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider | |
| NO774067L (no) | Fremgangsmaate for fremstilling av cellulosemasse | |
| SE443142B (sv) | Forfarande for framstellning av rifamycinforeningar | |
| SE440500B (sv) | Forfarande for framstellning av optiskt aktiva antracyklinoner | |
| NO149175C (no) | Fremgangsmaate til fremstilling av antibakterielt aktive rifamycin p-derivater | |
| NO780644L (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater | |
| NO146600C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater | |
| SE7700572L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| SE436496B (sv) | Forfarande for framstellning av dibensotiofenderivat | |
| NO143345C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyl-2-hydroksyetylaminderivater |